We serve 4-(1-Cyclohexen-1-yl)morpholine CAS:670-80-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(1-Cyclohexen-1-yl)morpholine
CAS.NO:670-80-4
Molecular Formula: C10H17NO
Molecular Weight: 167.24800
Synonyms:
4-(cyclohexen-1-yl)morpholine
Physical and Chemical Properties:
Density: 0.995 g / mL at 25 ° C (lit.)
Boiling point: 118-120 ° C10 mm Hg (lit.)
Flash point: 155 ° F
Refractive index: n20 / D 1.514 (lit.)
Specification:
Appearance:Colorless liquid
Purity:≥98.0%
Moisture Content: 0.25%
Impurity: 0.3%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.
Contact us for information like 4-(1-Cyclohexen-1-yl)morpholine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(cyclohexen-1-yl)morpholine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(cyclohexen-1-yl)morpholine Use and application,4-(cyclohexen-1-yl)morpholine technical grade,usp/ep/jp grade.
Related News: To date, eight cases have been confirmed in the US: three people in California, two in Illinois and one individual each in Massachusetts, Washington State, and Arizona.3-[4-(Benzyloxy)Phenyl]Acrylic Acid manufacturer The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.2,5-Dimethyl pyrazine supplier The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.Phenylboronic acid vendor The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.
